BrainsWay Ltd. BWAY
11.14 USD +0.05 (+0.45%)
Nov 3, 2026, 3:57 PM EST
11.00 Day range 11.33
7.14 52-week range 17.40
- YTD
- +17.14%
- 1 year
- +28.19%
- Market cap
- 448.02M
- Revenue (ttm)
- 36.43M
- Profit margin
- 1.67%
- EPS (ttm)
- 0.23
- Shares out
- 18.81M
- P/E ratio
- 48.39
- Forward P/E
- 91.50
- YTD return
- +17.14%
- 1-year return
- +28.19%
- Volume
- 35.39K
- Avg volume
- 106.91K
- Open
- 11.00
- Previous close
- 11.09
- Day's range
- 11.00 – 11.33
- 52-week range
- 7.14 – 17.40
- Beta
- 0.37
- Price target
- 13.73 (+23.2%)
- Earnings date
- Aug 6, 2024
2Y +5.90 (+114.34%)
Key statistics
- Enterprise value
- 243.14M
- PEG ratio
- 0.00
- Price / sales
- 4.73
- Price / book
- 7.31
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 27.80%
- Free cash flow
- 3.16M
- Total cash
- 47.86M
- Total debt
- 0
- Return on equity
- 1.44%
- Short % of float
- 0.33%
- 50-day average
- 9.84
- 200-day average
- 7.41
Analyst view
Price target (mean) 13.73 +23.2% upside
Now 11.14
- Target (low)
- 12.50
- Target (mean)
- 13.73
- Target (high)
- 16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 6, 2024
Expected Aug 6, 2024. Consensus EPS estimate 0.02.
Financials — quick view
BWAY Revenue — quarterly 17.11M
BWAY Net income — quarterly 2.71M
BWAY EPS — quarterly 0.07
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.01 | 0.04 | +0.03 | +300.00% |
| Aug 6, 2024 | Jun 1, 2024 | 0.00 | 0.04 | — | — |
| Aug 6, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Mar 6, 2024 | Dec 1, 2023 | -0.03 | — | — | — |
| Mar 6, 2024 | Dec 1, 2023 | -0.03 | 0.01 | +0.04 | +133.33% |
| Nov 15, 2023 | Sep 1, 2023 | -0.07 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 23, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 21, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 3, 2024 | Northland Capital Markets | main | Outperform | Outperform |
| Sep 16, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 8, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 7, 2024 | Northland Capital Markets | main | Outperform | Outperform |
About BrainsWay Ltd.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Israel
- Website
- brainsway.com
News
BrainsWay Partners With Mindful Health Solutions To Pursue Strategic Initiatives To Expand Patient Access To Health Treatments 
BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026 
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives - HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
BrainsWay, Inland Psychiatric Collaborate On Multi-System Deep TMS Deployment And Mental Health Research Initiatives 
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group 
Bumble, Fermi, Xtend AI Robotics And Other Big Stocks Moving Higher On Tuesday 
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives 
HWG Holdings LP Buys New Stake in Brainsway Ltd. Sponsored ADR $BWAY 
Head to Head Survey: CapsoVision (NASDAQ:CV) vs. Brainsway (NASDAQ:BWAY)
Your note
Sign in to keep a note on BWAY — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Masters Capital Management, LLC | 4.78% | 900,000 | 8.23M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.92% | 361,160 | 3.30M | Sep 29, 2024 |
| Essex Investment Management Co LLC | 1.85% | 347,761 | 3.18M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 1.57% | 295,142 | 2.70M | Sep 29, 2024 |
| DAFNA Capital Management, LLC | 1.34% | 251,346 | 2.30M | Sep 29, 2024 |
| Phoenix Holdings Ltd. | 1.28% | 240,358 | 2.20M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Israel Innovative Technology ETF | 1.07% | 201,670 | 1.85M | Oct 30, 2024 |
| 1290 Fds-1290 Essex Small Cap Growth Fd | 0.33% | 61,736 | 564.88K | Jul 30, 2024 |
| Trust for Professional Managers-ActivePassive International Equity ETF | 0.18% | 33,784 | 309.12K | Aug 30, 2024 |
| Perritt Ultra MicroCap Fund | 0.11% | 20,000 | 183.00K | Jul 30, 2024 |
| Voya International Small Cap Fund | 0.03% | 4,917 | 44.99K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 5,012 | 45.86K | Oct 30, 2024 |